Bulletin
Investor Alert

Illumina Inc.

NAS: ILMN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 27, 2023, 7:59 p.m.

/zigman2/quotes/203509482/composite

$

213.99

Change

-0.04 -0.02%

Volume

Volume 36,293

Quotes are delayed by 20 min

/zigman2/quotes/203509482/composite

Previous close

$ 212.78

$ 214.03

Change

+1.25 +0.59%

Day low

Day high

$207.83

$215.09

Open

52 week low

52 week high

$173.45

$371.16

Open

Robert S. Epstein

Founder of Epstein Health LLC, Robert S. Epstein is a businessperson who has been at the head of 6 different companies and currently holds the position of Chairman & Chief Executive Officer of Epstein Health LLC, Managing Director at Biologics & Biosimilars Collective Intelligence Consortium and Chairman at Decipher Biosciences, Inc. He is also on the board of Illumina, Inc., Veracyte, Inc., Fate Therapeutics, Inc. and Intellos Health LLC.

In the past he occupied the position of President for Medco Research Institute LLC, President of Health Outcomes Research Europe SL, Chief Research & Development Officer at Medco Health Solutions, Inc. and President at International Society for Pharmacoeconomics & Outcomes Rsch.

Robert S. Epstein received a doctorate and an undergraduate degree from the University of Michigan and a graduate degree from the University of Maryland.

Transactions

Date Shares Transaction Value
05/26/2022 1,232   Award at $0 per share. 0
05/26/2021 881   Award at $0 per share. 0
05/25/2021 385   Derivative/Non-derivative trans. at $397.09 per share. 152,880
05/27/2020 963   Award at $0 per share. 0
05/29/2019 1,298   Award at $0 per share. 0
05/23/2019 589   Derivative/Non-derivative trans. at $308.97 per share. 181,984
05/01/2019 200   Disposition at $312.16 per share. 62,432
05/01/2019 1,372   Disposition at $311.23 per share. 427,008
05/01/2019 2,228   Disposition at $310.29 per share. 691,327
05/01/2019 1,200   Disposition at $309.51 per share. 371,412
05/01/2019 5,000   Derivative/Non-derivative trans. at $51.17 per share. 255,850
04/01/2019 1,000   Disposition at $314.45 per share. 314,450
04/01/2019 1,000   Derivative/Non-derivative trans. at $51.17 per share. 51,170
03/01/2019 1,000   Disposition at $313.93 per share. 313,930
03/01/2019 1,000   Derivative/Non-derivative trans. at $51.17 per share. 51,170
02/01/2019 1,000   Disposition at $280.11 per share. 280,110
02/01/2019 1,000   Derivative/Non-derivative trans. at $51.17 per share. 51,170
01/02/2019 1,000   Disposition at $294.71 per share. 294,710
01/02/2019 1,000   Derivative/Non-derivative trans. at $51.17 per share. 51,170
12/27/2018 1,500   Gift at $0 per share. 0
12/03/2018 1,345   Disposition at $343.57 per share. 462,102
12/03/2018 1,000   Derivative/Non-derivative trans. at $51.17 per share. 51,170
11/01/2018 1,346   Disposition at $311.86 per share. 419,764
11/01/2018 1,000   Derivative/Non-derivative trans. at $51.17 per share. 51,170
10/01/2018 1,346   Disposition at $369.15 per share. 496,876
10/01/2018 1,000   Derivative/Non-derivative trans. at $51.17 per share. 51,170
09/07/2018 1,346   Disposition at $345.14 per share. 464,559
09/07/2018 1,000   Derivative/Non-derivative trans. at $51.17 per share. 51,170
07/23/2018 500   Disposition at $311.15 per share. 155,575
06/21/2018 500   Disposition at $288.45 per share. 144,225
05/23/2018 1,473   Award at $0 per share. 0
05/22/2018 922   Derivative/Non-derivative trans. at $270.8 per share. 249,678
05/21/2018 500   Disposition at $271 per share. 135,500
02/28/2018 250   Disposition at $231.25 per share. 57,813
01/29/2018 1,250   Disposition at $244.18 per share. 305,225
01/29/2018 1,000   Derivative/Non-derivative trans. at $51.17 per share. 51,170

Officers and Executives

Mr. Francis A. deSouza
President, Chief Executive Officer & Director
Mr. Kevin Pegels
Chief-Global Operations
Dr. Joydeep Goswami
Chief Financial & Strategy Officer
Dr. Alex Aravanis
CTO, Head-Research & Product Development
Ms. Carissa Rollins
Chief Information Officer
Dr. Phillip G. Febbo
Chief Medical Officer
Ms. Susan H. Tousi
Chief Commercial Officer
Dr. Craig Michael Ciesla
Vice President
Dr. Bryan Crane
Vice President & Head-System Design
Mr. Charles E. Dadswell
Secretary & General Counsel
Ms. Paula Lynn Dowdy
SVP & GM-Commercial Operations, Europe
Ms. Kathryne Reeves
Chief Marketing Officer
Mr. Scott Ericksen
Ms. Sallilyn Schwartz
Vice President-Investor Relations
Ms. Aimee Hoyt
Chief People Officer & Senior Vice President
Mr. John Frank
Chief Public Affairs Officer
Dr. John Wendell Thompson
Chairman
Dr. Scott Gottlieb
Independent Director
Dr. Robert S. Epstein
Independent Director
Dr. Frances Hamilton Arnold
Independent Director
Mr. Philip W. Schiller
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Gary S. Guthart
Independent Director
Ms. Susan E. Siegel
Independent Director
Link to MarketWatch's Slice.